Arkolith/Insider Trading/CRVS/Form 4

Thompson Peter A.

Director, 10% OwnerCorvus Pharmaceuticals, Inc. (CRVS) · full profile →Form 4 · filed Jan 30, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
26
13 non-derivative · 13 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 28, 2026Option exercise(M)30K$15.00$450K30K
Jan 28, 2026Option exercise(M)15K$9.70$146K45K
Jan 28, 2026Option exercise(M)15K$12.50$188K60K
Jan 28, 2026Option exercise(M)15K$3.61$54K75K
Jan 28, 2026Option exercise(M)15K$2.00$30K90K
Jan 28, 2026Option exercise(M)15K$3.27$49K105K
Jan 28, 2026Option exercise(M)15K$2.12$32K210K
Jan 28, 2026Option exercise(M)15K$2.60$39K135K
Jan 28, 2026Option exercise(M)15K$0.99$15K150K
Jan 28, 2026Option exercise(M)15K$0.97$15K165K
Jan 28, 2026Option exercise(M)15K$2.49$37K180K
Jan 28, 2026Option exercise(M)15K$1.64$25K195K
Jan 28, 2026Option exercise(M)15K$2.74$41K120K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 28, 2026Option exercise(M)15K—$00
Jan 28, 2026Option exercise(M)15K—$00
Jan 28, 2026Option exercise(M)15K—$00
Jan 28, 2026Option exercise(M)15K—$00
Jan 28, 2026Option exercise(M)15K—$00
Jan 28, 2026Option exercise(M)15K—$00
Jan 28, 2026Option exercise(M)30K—$00
Jan 28, 2026Option exercise(M)15K—$00
Jan 28, 2026Option exercise(M)15K—$00
Jan 28, 2026Option exercise(M)15K—$00
Jan 28, 2026Option exercise(M)15K—$00
Jan 28, 2026Option exercise(M)15K—$00
Jan 28, 2026Option exercise(M)15K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-26-000079) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML